Diagnosing and treating acute myocardial infarction in pregnancy
Pregnancy associated with acute myocardial infarction (AMI), is rare but is associated with a high incidence of mortality and mortality of both the mother and fetus. According to Uebing et al, approximately 250,000 adults have congenital heart disease in the UK. Half of these patients are women, most of reproductive age. The incidence of AMI during pregnancy is 3 to 10 cases per 100,000 deliveries with an overall maternal mortality rate of 21% and fetal mortality rate of 13%. Nurses have a challenge when caring for a person with this symptom. The presenting sign and symptoms of AMI in pregnancy can mimic regular pregnancy symptoms and therefore may be misdiagnosed. It is suggested that physicians caring for a women during pregnancy become mindful of the occasional occurrence of AMI, and not overlook symptoms in young patients. A case study was performed on a 34 year old female who came into the emergency room with severe chest pain and sweating. Her ECG reported acute ST elevation in leads 2, AVF and V5 and V6. In her case, risk factors were noted: A positive family history of ischemic heart disease, smoker, and abnormal cholesterol. Troponin test was performed on this patient. On admission her results was 0.4 and then the second Troponin I recorded 6-8hrs was 12.82. Troponin is a test that measures the amount of troponins in blood. Troponins are a muscle protein. It is used to evaluate injury to the heart, or a blocked artery in a lung (pulmonary emboli), or in the brain (thromboembolic stroke). Adult’s Normal levels of Troponin I is: 0-0.4 mg/mL. She was treated with oral antiplatelet agents and intravenous beta blocker to control the heartbeat. Increasing the knowledge of all healthcare professionals in the screening of risk factors, and highlighting the importance of all healthcare workers, who are caring for a their patient, to effectively communicate with one another and diagnose and...
Please join StudyMode to read the full document